The clinical and pathological characteristics of Chinese patients with pauci‐immune crescentic glomerulonephritis

SUMMARY In the present study, we investigated pauci‐immune crescentic glomerulonephritis (PICGN) in Chinese patients. During 13 years (1985–98), 6400 patients underwent non‐transplanting renal biopsy in the Nanjing Jinling Hospital. Twenty‐four patients were diagnosed as having PICGN. They were 16 women and eight men with a median age of 33 (range 10–76 years). Microscopic polyarteritis (33.3%) and polyarteritis nodosa (8.3%) were the secondary diseases. The incidence of PICGN was 0.37% in renal biopsies and 22.9% in crescentic glomerulonephritis. Clinically, most patients (75.0%) showed rapidly progressive nephritis with enlarged kidneys. Onset gross haematuria was noted in 58.3% of the patients, hypertension 45.8%, nephrotic syndrome 41.7%, and oliguria 25.0%. However, systemic symptoms were rare except anaemia. Pathologically, we observed necrosis of glomerular capillaries (62.5%), infiltration of monocytes and neutrophil cells in glomeruli (66.7%), and vasculitis in interstitium (53.3%), in addition to glomerulosclerosis more than 50% (45.8%), severe tubular atrophy (83.3%) and interstitial fibrosis (75.0%). Antineutrophil cytoplasmic antibodies were positive in 52.2%. All patients except two received intensively immunosuppressive therapy. Sixteen patients were subjected to long‐term follow up (median 29.8, range 8–92 months), 12 of them had life‐sustaining renal function, four had normal range of serum creatinine (< 124 μmol/L), only four patients were dialysis dependent.

[1]  Z. Tang,et al.  Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis. , 1997, Chinese Medical Journal.

[2]  R. Johnson,et al.  The mystery of the antineutrophil cytoplasmic antibodies. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  E. Pettersson,et al.  Incidence and outcome of pauci-immune necrotizing and crescentic glomerulonephritis in adults. , 1995, Clinical nephrology.

[4]  R. Zent,et al.  Crescentic nephritis at Groote Schuur Hospital, South Africa--not a benign disease. , 1994, Clinical nephrology.

[5]  P. Tipping,et al.  Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. , 1994, Kidney international.

[6]  E. Ritz,et al.  Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. , 1991, Nephron.

[7]  T. Carey,et al.  Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. , 1990, Annals of internal medicine.

[8]  W. Couser Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  D. Kaiser,et al.  T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations. , 1987, Kidney international.

[10]  L R Muenz,et al.  Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. , 1984, Kidney international.